(1)
Peaucelle, A.-S.; Gay, C.; Lefevre, M.-A.; Barrau, M.; Boschetti, G.; Nancey, S.; Roblin, X. An Unusual Skin Adverse Event After Switching from Intravenous to Subcutaneous VEDOLIZUMAB Therapy in Patients With Ulcerative Colitis. acmcr 2023, 7, 77-79.